BioSpace News Archive

IMBiotechnologies Ltd. (“IMB” or the “Company”) today announced that it has signed an agreement with Canadian Hospital Specialties (“CHS”) for the exclusive right to distribute Ekobi® Embolization Microspheres (“Ekobi”) in Canada. “CHS has expertise in the distribution of a broad range of medical d

MJ Biotech Inc. is pleased to announce that it’s subsidiary New England Biotech’s partner Genesis Botanical, has begun construction of the CBD Extraction facility after securing a location.

Pharma Industry Veteran in Vaccines will Assume Role Full Time March 2, 2021, with Focus on Developing Product Pipeline in Infectious Diseases

David D. Cox, PhD, MBA, seasoned regulatory professional, tapped to lead CytoSorbents global regulatory initiatives and U.S. FDA approval of CytoSorb

management team at ELNA Medical is delighted to welcome Ravi Deshpande as Chief Business Development Officer, Canada.

Based on a scientifically solid proof of concept in dogs and cats, an international IP portfolio, and a comprehensive scientific advisory board that includes key opinion leaders and experienced management, CureLab Veterinary intends to raise initial financing through a crowdfunding campaign set to launch within a month, and to become profitable within 36 months of raising funds.

Acquisition of external cardiac monitoring technologies and services provider to expand rhythm management diagnostics portfolio and capabilities

Cerevel Therapeutics , a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today that it has appointed the Honorable Deval Patrick and Deborah Baron to serve as independent members of its Board of Directors. Mr. Patrick, a former two-term governor of Massachusetts, is an experienced business and government leader with a deep understanding of the life sciences ecosystem. He currently serves

The Sara Schottenstein Foundation, a science-focused organization dedicated to ending gastric cancer, today announced its launch and new website, http://www.saraschottensteinfoundation.org/ . Founded by Jeff Schottenstein , a wealth manage

Sutro Biopharma, Inc. today announced the dosing of the first patient in the dose-expansion cohort of Phase 1 study.